ADVFN ADVFN

Hot Features

Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Inovio Pharmaceuticals Inc New

Inovio Pharmaceuticals Inc New (INO)

1.07
-0.09
(-7.76%)
終了 6月6日 5:00AM
1.09
0.02
(1.87%)
取引時間後: 8:35AM

Inovio Pharmaceuticals Inc New (INO) インサイダー取引

-
フィルター:
日付 保有者名 取引株数 金額レンジ ($) 取引種別 価格レンジ ($) 届出終了時の株数 % 変化
2026-05-20Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board3.86k0.00Derivative Exercise and Retained Stock-46.82k8.99%
2026-05-20Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board-2.16k2.66kDerivative Exercise and Sale1.2346.82k-
2026-05-20Dr. Michael SumnerChief Medical Officer & Head of Development-2.69k3.31kDerivative Exercise and Sale1.2342.04k-
2026-05-20Dr. Michael SumnerChief Medical Officer & Head of Development6.76k0.00Derivative Exercise and Retained Stock-42.04k19.15%
2026-05-20Mr. Peter D. KiesCFO4.01k0.00Derivative Exercise and Retained Stock-43.23k10.23%
2026-05-20Mr. Peter D. KiesCFO-4.69k5.77kDerivative Exercise and Sale1.2343.23k-
2026-05-20Dr. Jacqueline E. SheaCEO, President & Director15.99k0.00Derivative Exercise and Retained Stock-111.02k16.83%
2026-05-20Dr. Jacqueline E. SheaCEO, President & Director-12.31k15.14kDerivative Exercise and Sale1.23111.02k-
2026-05-15Mr. Peter D. KiesCFO2.20k0.00Derivative Exercise and Retained Stock-39.22k5.94%
2026-05-15Mr. Peter D. KiesCFO-2.57k3.34kDerivative Exercise and Sale1.3039.22k-
2026-05-15Dr. Jacqueline E. SheaCEO, President & Director10.03k0.00Derivative Exercise and Retained Stock-95.03k11.80%
2026-05-15Dr. Jacqueline E. SheaCEO, President & Director-7.72k10.03kDerivative Exercise and Sale1.3095.03k-
2026-05-15Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board3.06k0.00Derivative Exercise and Retained Stock-42.96k7.67%
2026-05-15Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board-1.71k2.23kDerivative Exercise and Sale1.3042.96k-
2026-05-15Dr. Michael SumnerChief Medical Officer & Head of Development1.71k0.00Derivative Exercise and Retained Stock-35.28k5.08%
2026-05-15Dr. Michael SumnerChief Medical Officer & Head of Development-680.00884.00Derivative Exercise and Sale1.3035.28k-
2026-03-31Dr. Michael SumnerChief Medical Officer & Head of Development3.07k0.00Derivative Exercise and Retained Stock-33.58k10.06%
2026-03-31Dr. Michael SumnerChief Medical Officer & Head of Development-1.22k2.13kDerivative Exercise and Sale1.7433.58k-
2026-02-26Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board7.28k0.00Derivative Exercise and Retained Stock-39.90k22.31%
2026-02-26Dr. Laurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board-5.10k9.13kDerivative Exercise and Sale1.7939.90k-
2026-02-26Mr. Peter D. KiesCFO6.39k0.00Derivative Exercise and Retained Stock-37.02k20.84%
2026-02-26Mr. Peter D. KiesCFO-9.26k16.57kDerivative Exercise and Sale1.7937.02k-
2026-02-26Dr. Jacqueline E. SheaCEO, President & Director25.32k0.00Derivative Exercise and Retained Stock-85.00k42.42%
2026-02-26Dr. Jacqueline E. SheaCEO, President & Director-21.71k38.87kDerivative Exercise and Sale1.7985.00k-
2026-02-26Dr. Michael SumnerChief Medical Officer & Head of Development12.66k0.00Derivative Exercise and Retained Stock-30.51k70.91%
2026-02-26Dr. Michael SumnerChief Medical Officer & Head of Development-3.90k6.99kDerivative Exercise and Sale1.7930.51k-
2026-02-26Dr. David B. WeinerMember of the Scientific Advisory Board & Director972.000.00Derivative Exercise and Retained Stock-87.59k1.12%
2025-06-30Dr. Michael SumnerChief Medical Officer & Head of Development2.92k0.00Derivative Exercise and Retained Stock-17.85k19.53%